Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo In Charge, And The World Is GSK/Novartis Consumer Product JV’s Oyster

This article was originally published in The Tan Sheet

Executive Summary

GSK Consumer Healthcare not only is the name of Glaxo/Novartis JV, but also the brand being added to Novartis’ OTC products. The JV will access OTC switch opportunities across the Rx portfolios of both Glaxo and Novartis in addition to external partners, says Americas/Europe head Brian McNamara.

Advertisement

Related Content

GSK Trims Nutritional Drink Lines, Wants All Of Its Consumer JV Pie
GSK Trims Nutritional Drink Lines, Wants All Of Its Consumer JV Pie
J&J Settlement With States Not Likely To Be Precedent In OTC Space
GSK Aims Flonase Sensimist To Counter Generic Nasal Allergy Competition
Flonase Allergy Relief Exclusivity Sliced Up By Label Carve-Out

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS107712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel